Clinical Trial Update: Percutaneous Removal and Margin Ablation for Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating percutaneous removal and margin ablation as a treatment for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED